February 26, 2020
Article
Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.
Investigating RBX2660 for Recurrent C Difficile Infection
Examining Oral Vancomycin as a First-Line CDI Therapy
The Latest on Monkeypox
Assessing Vancomycin and Metronidazole Susceptibility for CDI